RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
West Pharmaceutical Services Stock

West Pharmaceutical Services EBIT 2024

West Pharmaceutical Services EBIT

581.83 M USD

Ticker

WST

ISIN

US9553061055

WKN

864330

In 2024, West Pharmaceutical Services's EBIT was 581.83 M USD, a -17.48% increase from the 705.1 M USD EBIT recorded in the previous year.

The West Pharmaceutical Services EBIT history

YEAREBIT (undefined USD)
2028e-
2027e-
2026e825.02
2025e717.56
2024e581.83
2023705.1
2022754.9
2021757.2
2020417.7
2019297.9
2018250.5
2017240
2016225.9
2015128.6
2014181.1
2013161.9
2012141.7
2011119.3
2010108.3
2009106.4
2008125.2
2007113
2006105.7
200573.2
200451.8

West Pharmaceutical Services Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into West Pharmaceutical Services, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by West Pharmaceutical Services from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects West Pharmaceutical Services’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of West Pharmaceutical Services. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into West Pharmaceutical Services’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing West Pharmaceutical Services’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on West Pharmaceutical Services’s growth potential.

West Pharmaceutical Services Revenue, EBIT and net profit per share

DateWest Pharmaceutical Services RevenueWest Pharmaceutical Services EBITWest Pharmaceutical Services Net Income
2028e4.78 B undefined0 undefined0 undefined
2027e3.89 B undefined0 undefined809.58 M undefined
2026e3.37 B undefined825.02 M undefined664.41 M undefined
2025e3.1 B undefined717.56 M undefined571.18 M undefined
2024e2.9 B undefined581.83 M undefined477.03 M undefined
20232.95 B undefined705.1 M undefined593.4 M undefined
20222.89 B undefined754.9 M undefined585.9 M undefined
20212.83 B undefined757.2 M undefined661.8 M undefined
20202.15 B undefined417.7 M undefined346.2 M undefined
20191.84 B undefined297.9 M undefined241.7 M undefined
20181.72 B undefined250.5 M undefined206.9 M undefined
20171.6 B undefined240 M undefined150.7 M undefined
20161.51 B undefined225.9 M undefined143.6 M undefined
20151.4 B undefined128.6 M undefined95.6 M undefined
20141.42 B undefined181.1 M undefined127.1 M undefined
20131.37 B undefined161.9 M undefined112.3 M undefined
20121.27 B undefined141.7 M undefined80.7 M undefined
20111.19 B undefined119.3 M undefined75.5 M undefined
20101.1 B undefined108.3 M undefined65.3 M undefined
20091.06 B undefined106.4 M undefined72.6 M undefined
20081.05 B undefined125.2 M undefined86 M undefined
20071.02 B undefined113 M undefined70.7 M undefined
2006913.3 M undefined105.7 M undefined67.1 M undefined
2005699.7 M undefined73.2 M undefined46.4 M undefined
2004541.6 M undefined51.8 M undefined20.2 M undefined

West Pharmaceutical Services stock margins

The West Pharmaceutical Services margin analysis displays the gross margin, EBIT margin, as well as the profit margin of West Pharmaceutical Services. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for West Pharmaceutical Services.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the West Pharmaceutical Services's sales revenue. A higher gross margin percentage indicates that the West Pharmaceutical Services retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the West Pharmaceutical Services's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the West Pharmaceutical Services's total revenue generated. When comparing the revenue margin year over year, investors can gauge the West Pharmaceutical Services's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the West Pharmaceutical Services. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the West Pharmaceutical Services's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

West Pharmaceutical Services Margin History

West Pharmaceutical Services Gross marginWest Pharmaceutical Services Profit marginWest Pharmaceutical Services EBIT marginWest Pharmaceutical Services Profit margin
2028e38.28 %0 %0 %
2027e38.28 %0 %20.81 %
2026e38.28 %24.5 %19.73 %
2025e38.28 %23.12 %18.4 %
2024e38.28 %20.05 %16.44 %
202338.28 %23.9 %20.12 %
202239.36 %26.15 %20.3 %
202141.59 %26.74 %23.37 %
202035.76 %19.46 %16.13 %
201932.92 %16.19 %13.14 %
201831.76 %14.59 %12.05 %
201732.06 %15.01 %9.42 %
201633.21 %14.97 %9.52 %
201532.56 %9.19 %6.83 %
201431.5 %12.74 %8.94 %
201331.77 %11.83 %8.21 %
201230.61 %11.19 %6.37 %
201128.46 %10.01 %6.33 %
201028.8 %9.8 %5.91 %
200928.76 %10.08 %6.88 %
200828.79 %11.91 %8.18 %
200727.61 %11.08 %6.93 %
200628.99 %11.57 %7.35 %
200528.08 %10.46 %6.63 %
200429.01 %9.56 %3.73 %

West Pharmaceutical Services Aktienanalyse

What does West Pharmaceutical Services do?

West Pharmaceutical Services Inc. is a leading company in the development and manufacturing of innovative solutions for drug delivery and medical devices. The company has been in the market for over 100 years and is headquartered in Exton, Pennsylvania, USA. West operates in more than 50 countries worldwide and employs over 9,000 employees. The history of West Pharmaceutical Services begins in 1923, when Herman O. West founded the company in Philadelphia. Initially, West primarily produced rubber seals for canning jars and bottle closures. In the 1930s, West entered the production of plastic parts used in products such as tube radios. In the mid-1950s, West began to venture into the production of medical devices and accessories, such as syringe stoppers. Since then, the company has continuously expanded its product range and is now a leading provider of pharmaceutical delivery solutions. West is divided into three business segments: Healthcare Delivery Systems (HDS), Pharmaceutical Packaging Systems (PPS), and Contract Manufacturing Organization (CMO). The Healthcare Delivery Systems (HDS) segment specializes in the development and manufacturing of devices and systems for drug delivery. This includes syringes, injection devices, pen systems, nasal and inhalation devices. These products are developed in collaboration with various pharmaceutical companies to simplify and improve medication delivery. West has also developed many patented products, such as the "SmartDose" system, which enables accurate dosage delivery. The Pharmaceutical Packaging Systems (PPS) segment offers packaging solutions for pharmaceuticals. This includes injection vials, caps, and closures made of glass or plastic. PPS has also developed specialized packaging solutions, such as the "Ready Pack" solution, which packages sterile products in a safe and user-friendly environment. Another example is the "Westar UD" system, which allows for accurate and safe dosing of medications in ampoules. The Contract Manufacturing Organization (CMO) segment offers customized services, including design and development of packaging solutions and manufacturing of pharmaceuticals and medical devices. CMO manufacturing services include development, manufacturing, filling, and packaging of sterility products. West has a wide customer base in the pharmaceutical and biotech industry. The company works closely with its customers to develop customized solutions that meet their specific needs. West also has strong partnerships with other leading companies in the industry, such as Merck or Daikyo. Overall, West Pharmaceutical Services is distinguished by its high focus on quality and safety. The company places great emphasis on compliance with regulatory requirements and the use of safety-conscious manufacturing technologies. West also has its own quality control department, which ensures the high quality of its products and satisfies its customers. In summary, West Pharmaceutical Services is a leading provider of pharmaceutical delivery solutions and packaging solutions. With a wide portfolio of innovative products and services tailored to meet customer needs, West can provide safe and effective solutions to its customers worldwide. West Pharmaceutical Services ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing West Pharmaceutical Services's EBIT

West Pharmaceutical Services's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of West Pharmaceutical Services's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

West Pharmaceutical Services's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in West Pharmaceutical Services’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about West Pharmaceutical Services stock

How much did West Pharmaceutical Services achieve in EBIT for the current year?

In the current year, West Pharmaceutical Services has achieved an EBIT of 581.83 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company West Pharmaceutical Services.

How has the EBIT of West Pharmaceutical Services developed in recent years?

The EBIT of West Pharmaceutical Services has increased by -17.483% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company West Pharmaceutical Services?

The EBIT of West Pharmaceutical Services is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does West Pharmaceutical Services pay?

Over the past 12 months, West Pharmaceutical Services paid a dividend of 0.77 USD . This corresponds to a dividend yield of about 0.26 %. For the coming 12 months, West Pharmaceutical Services is expected to pay a dividend of 0.92 USD.

What is the dividend yield of West Pharmaceutical Services?

The current dividend yield of West Pharmaceutical Services is 0.26 %.

When does West Pharmaceutical Services pay dividends?

West Pharmaceutical Services pays a quarterly dividend. This is distributed in the months of December, February, May, August.

How secure is the dividend of West Pharmaceutical Services?

West Pharmaceutical Services paid dividends every year for the past 53 years.

What is the dividend of West Pharmaceutical Services?

For the upcoming 12 months, dividends amounting to 0.92 USD are expected. This corresponds to a dividend yield of 0.31 %.

In which sector is West Pharmaceutical Services located?

West Pharmaceutical Services is assigned to the 'Health' sector.

Wann musste ich die Aktien von West Pharmaceutical Services kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of West Pharmaceutical Services from 8/7/2024 amounting to 0.2 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did West Pharmaceutical Services pay the last dividend?

The last dividend was paid out on 8/7/2024.

What was the dividend of West Pharmaceutical Services in the year 2023?

In the year 2023, West Pharmaceutical Services distributed 0.73 USD as dividends.

In which currency does West Pharmaceutical Services pay out the dividend?

The dividends of West Pharmaceutical Services are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The West Pharmaceutical Services stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von West Pharmaceutical Services

Our stock analysis for West Pharmaceutical Services Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of West Pharmaceutical Services Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.